SCHEMBL31577359

SCHEMBL31577359

CNc1nc(Nc2cnn(CC(F)F)c2C)c(C(N)=O)nc1-c1nc2ccncc2n1C

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ BUB1 O43683 7/20 0.33
▸ LRRK2 Q5S007 1/20 0.32
▸ TGFBR1 P36897 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24944362 0.79 LRRK2 (0.33) BUB1LRRK2
SCHEMBL30205482 0.79 LRRK2 (0.33) BUB1LRRK2
SCHEMBL31577339 0.78 BMI1 (0.37) —
SCHEMBL31577293 0.76 RPS6KA5 (0.41) —
SCHEMBL31577363 0.74 AOC3 (0.37) —
SCHEMBL31577323 0.73 NAMPT (0.30) —
SCHEMBL30206155 0.70 LRRK2 (0.35) BUB1LRRK2
SCHEMBL29173593 0.70 LRRK2 (0.35) BUB1LRRK2
SCHEMBL31577281 0.70 RPS6KA5 (0.41) —
SCHEMBL31577326 0.69 RPS6KA5 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4373817-B1 SUBSTITUTED PYRAZINE-2-CARBOXAMIDES AS HPK1 INHIBITORS FOR THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2025-05-21 — — EP disclosed
Send feedback